Latest News and Press Releases

BOTHELL, WA--(Marketwire - October 6, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the Intellectual Property...

BOTHELL, WA--(Marketwire - September 22, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, today announced that the first patient has received a...

BOTHELL, WA--(Marketwire - September 13, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, today reported results from in vivo studies in...

BOTHELL, WA--(Marketwire - September 7, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNA), formerly known as MDRNA, Inc., a leading RNAi-based drug discovery and development company, announced today...

BOTHELL, WA--(Marketwire - August 30, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark...

BOTHELL, WA--(Marketwire - August 26, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNA) announced today that it has entered into an Asset Purchase Agreement with Cypress Bioscience, Inc. (NASDAQ:...

BOTHELL, WA--(Marketwire - August 24, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark...

BOTHELL, WA--(Marketwire - August 12, 2010) - Marina Biotech, Inc. (NASDAQ: MRNAD), formerly MDRNA, Inc., a leading RNAi-based drug discovery and development company, today reported financial results...

BOTHELL, WA--(Marketwire - August 5, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNAD), formerly known as MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced...

BOTHELL, WA--(Marketwire - July 29, 2010) -  Marina Biotech, Inc. (NASDAQ: MRNAD), formerly known as MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that...